Published • loading... • Updated
The Excitement at the Domestic Production Plant for the Active Pharmaceutical Ingredient of the Antibiotic "penicillin"... Taking Serious Steps to Avoid China Risks in Pharmaceuticals, and Conducting Supply Chain Investigations.
Summary by toyokeizai.net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Can Japan break free from its dependence on China for the active pharmaceutical ingredient (API) of penicillin, the antibiotic that underpins Japanese healthcare? This report details the efforts of Meiji Seika Pharma's Gifu plant and the ongoing efforts toward domestic production, exploring the structural challenges and struggles of this China-dependent supply chain. What are the keys to a sustainable supply system? (This introductory paragraph …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
